Towards Healthcare
Molecular Cloning Market to Drive USD 8.89 Billion by 2034

Molecular Cloning Market Growth Drivers, Challenges and Opportunities

Projections indicate that, the global molecular cloning market will increase from USD 5.25 billion in 2024 to USD 8.89 billion by 2034, experiencing a CAGR of 5.4% over the next 10 years. Molecular cloning is used to produce identical DNA copies. Thus, it has various applications in biopharmaceuticals, genetic engineering, and agricultural production.

  • Insight Code: 5545
  • No. of Pages: 400
  • Format: PDF/PPT/Excel
  • Published: April 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

Molecular cloning can be used in biopharmaceuticals, genetic engineering, and agricultural production.

Thermo Fisher Scientific company is the major player in the molecular cloning market.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.